In-vivo
Tamanu oil potentiated novel sericin emulgel of levocetirizine: repurposing for topical delivery against DNCB-induced atopic dermatitis, QbD based development and in vivo evaluation.
Ravi Raj Pal, Poonam Parashar, Indu Singh, Shubhini A Saraf
In-vivoJournal of microencapsulation2019
Research Facts
Tamanu oil potentiated novel sericin emulgel of levocetirizine: repurposing for topical delivery against DNCB-induced atopic dermatitis, QbD based development and in vivo evaluation.
Ravi Raj Pal, Poonam Parashar, Indu Singh, Shubhini A Saraf
In-vivo ยท Moderate ยท 2019
Findings

When tamanu oil was combined with sericin (a silk protein) and the antihistamine levocetirizine, it reduced itching and redness in atopic dermatitis more effectively than standard gel formulas. The oil-based formula achieved 94% drug absorption efficiency and released the active ingredient steadily over 24 hours.

Design
In-vivo
Evidence
Moderate
Journal
Journal of microencapsulation
Methodology

Researchers created a tamanu oil microemulsion (tiny oil droplets suspended in liquid), optimized its formulation, then incorporated it into a gel. They tested the final product on atopic dermatitis in animal models, measuring itching frequency, skin inflammation, and cellular changes.

Funded By

Funding not disclosed in abstract